Position history for RTW INVESTMENTS, LP's holdings in CRINETICS PHARMACEUTICALS IN
RTW INVESTMENTS, LP holds 1.5M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $52.7M as of 2026-Q1. The position was increased (+7.4% shares). CRNX represents 0.5% of RTW INVESTMENTS, LP's portfolio.
Current Value
$52.7M
Current Shares
1.5M
Total Value Change
+$39.3M
Total Shares Change
+984,326
Other major holders of CRNX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.5M |
+7.4% |
| $52.7M |
| 0.5% |
| $40.12 |
45 |
| 2025-Q4 | Increased | 1.4M | +54.9% | $62.9M | 0.6% | $47.39 | 59 |
| 2025-Q3 | Increased | 872,387 | +86.8% | $36.3M | 0.4% | $43.51 | 54 |
| 2025-Q2 | New | 467,000 | - | $13.4M | 0.2% | $29.96 | 46 |